Erythromycin
Contents
Description
Erythromycin is a macrolide antibiotic with prokinetic properties that stimulate gastrointestinal motility through motilin receptor agonism. It is used off-label in managing intestinal dysmotility disorders including intestinal dysganglionosis and Berdon syndrome (megacystis-microcolon-intestinal hypoperistalsis syndrome). The prokinetic effect helps improve intestinal transit in patients with severe dysmotility.
Indications & Therapeutic Use
Bacterial infections, gastroparesis, intestinal dysmotility disorders (off-label)
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Erythromycin — GNH India
120 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | Erythromycin |
| Brands | 1 brand available |
| Active Ingredient | Erythromycin |
| Drug Class | Bacterial infections |
| Manufacturer | Various |
| Dosage Forms | Oral tablets 250mg, 500mg; IV infusion; Oral suspension 200mg/5mL |
| Medical Code | J01FA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 2 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |